Cargando…
Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19
ABSTRACT: The outbreak of SARS-CoV-2 and deaths caused by it all over the world have imposed great concern on the scientific community to develop potential drugs to combat Coronavirus disease-19 (COVID-19). In this regard, lichen metabolites may offer a vast reservoir for the discovery of antiviral...
Autores principales: | Joshi, Tanuja, Sharma, Priyanka, Joshi, Tushar, Pundir, Hemlata, Mathpal, Shalini, Chandra, Subhash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323881/ https://www.ncbi.nlm.nih.gov/pubmed/32602074 http://dx.doi.org/10.1007/s11030-020-10118-x |
Ejemplares similares
-
Using Chou’s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors
por: Pundir, Hemlata, et al.
Publicado: (2020) -
Computational investigation of drug bank compounds against 3C-like protease (3CL(pro)) of SARS-CoV-2 using deep learning and molecular dynamics simulation
por: Joshi, Tushar, et al.
Publicado: (2021) -
Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CL(Pro)) of SARS-CoV-2: in silico study
por: Mathpal, Shalini, et al.
Publicado: (2022) -
Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study
por: Joshi, Tanuja, et al.
Publicado: (2021) -
QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
por: Ishola, Ahmed Adebayo, et al.
Publicado: (2021)